Onderneming ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Aandelen
1541
CNE100006624
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
14,48 HKD | +3,58% |
|
-0,69% | -51,57% |
Vakgebied
Aantal werknemers: 145
Verkoop per activiteit
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Cell Strain and Other Products
95,1
%
| 1 | 92,8 % | 0 | 95,1 % | -30,11% |
Testing Services
4,9
%
| 0 | 7,2 % | 0 | 4,9 % | -53,71% |
Verkoop per regio
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -31,82% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wen Zhi Tian
CEO | Chief Executive Officer | - | 01-06-15 |
Qi Ying Lu
CTO | Chief Tech/Sci/R&D Officer | - | 01-03-22 |
Song Li
CTO | Chief Tech/Sci/R&D Officer | - | 01-12-15 |
Zikai Xiong
PRN | Corporate Officer/Principal | - | 01-03-22 |
Ru liang Zhang
PRN | Corporate Officer/Principal | - | 01-02-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chi Tat Yeung
BRD | Director/Board Member | 55 | 01-06-22 |
Zhi Hua Yu
BRD | Director/Board Member | 57 | - |
Wen Zhi Tian
CEO | Chief Executive Officer | - | 01-06-15 |
Zhenping Zhu
BRD | Director/Board Member | - | - |
Xiao Yong Yu
BRD | Director/Board Member | 51 | - |
Song Li
CTO | Chief Tech/Sci/R&D Officer | - | 01-12-15 |
Cong Xu
BRD | Director/Board Member | - | - |
Kendall Smith
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 374 157 695 | 69 612 628 ( 18,61 %) | 0 | 18,61 % |
Bedrijfsgegevens
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd.
Building 15, Lane 1000 Zhangheng Road
200120, Zhangjiang Science City
+86 21 3801 6387
http://cn.immuneonco.com![Adres ImmuneOnco Biopharmaceuticals (Shanghai) Inc.(1541)](https://cdn.zonebourse.com/static/address/158607346.png)
Sector
Verkoop per activiteit
![Consensus](/images/consensus_flch.gif)
Chiffre d''affaires - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-51,57% | 694 mln. | |
+15,19% | 121 mld. | |
+19,91% | 114 mld. | |
-19,80% | 20,43 mld. | |
-16,19% | 16,55 mld. | |
-13,45% | 16,45 mld. | |
-44,35% | 15,59 mld. | |
+66,67% | 15,19 mld. | |
+2,13% | 13,54 mld. | |
+119,39% | 10,96 mld. |
- Beurs
- Aandelen
- Koers 1541
- Onderneming ImmuneOnco Biopharmaceuticals (Shanghai) Inc.